Cover Image
市場調查報告書

細胞學及HPV檢驗市場:全球產業分析、規模、佔有率、成長、趨勢,及2016∼2024年的預測

Cytology and HPV Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

出版商 Transparency Market Research 商品編碼 364455
出版日期 內容資訊 英文 109 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
細胞學及HPV檢驗市場:全球產業分析、規模、佔有率、成長、趨勢,及2016∼2024年的預測 Cytology and HPV Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
出版日期: 2016年07月07日 內容資訊: 英文 109 Pages
簡介

這幾年,對各種癌症的認識大幅提高,在公認早期發現和診斷的重要性之下,細胞學及人類乳突瘤病毒 (HPV) 檢驗等篩檢檢驗的引進擴大。全球細胞學及HPV檢驗市場,由於急速發展的醫療基礎設施和國內製造地堅定等,主要由於新興國家的持續性成長的機會所支撐。

本報告提供全球細胞學及HPV檢驗市場相關調查,市場促進因素與阻礙因素,市場機會與各市場區隔趨勢,及參與企業簡介彙整。

第1章 序論

第2章 摘要整理

第3章 細胞學及HPV檢驗市場

  • 簡介
  • 推動市場的要素
    • 全球子宮頸癌的發病率上升
    • HPV感染的發病率高
    • 對子宮頸癌篩檢的認識計劃的擴大
  • 阻礙要素
    • 恰當的主要醫療基礎設施的不足
    • 全球性認識度低阻礙市場成長
  • 機會
    • 新興經濟提供持續的成長機會
  • 市場魅力度分析
  • 波特五力分析
  • 競爭環境
    • 市場地位
    • 競爭策略
    • 建議
  • 流行病學
  • 市場區隔:各產品及服務
    • 檢驗系統
    • 檢驗化驗套件
    • 檢驗服務

第4章 市場區隔:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他
    • 巴西
    • 墨西哥
    • 其他各國

第5章 企業簡介

  • Abbott Laboratories, Inc
  • Arbor Vita Corporation
  • Becton, Dickinson and Company
  • Cepheid, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fujirebio Diagnostics, Inc.
  • Hologic, Inc.
  • OncoHealth Corporation
  • QIAGEN N.V

圖表

目錄

Cytology and HPV Testing Market: Snapshot

Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing.

The global market for cytology and HPV testing is presented with a host of sustained growth opportunities arising mainly from several emerging economies, where factors such as rapidly developing healthcare infrastructure and a strong local manufacturing base serve as major advantages. In addition to this, these markets still have immense scope for growth, unlike the near-saturated markets in developed countries.

Low-cost Labor in APAC a Major Attraction for Cytology and HPV Testing Cos

The cytology and HPV testing market can be geographically segmented into Europe, North America, Asia Pacific, and Rest of the World. North America is by far the largest market for cytology and HPV testing accounting for a 52.5% share in 2015. This can be attributed to the rising incidence of HPV infections and cervical cancer, the increasing number of awareness programs by government and private organizations, and the availability of technologically advanced diagnostic test kits. The Centers for Disease Control and Prevention states that an estimated 79 million people in the U.S. are infected with HPV, with around 14 million people newly infected each year. Each year, more than 11,000 women in the country are diagnosed with cervical cancer.

The rising adoption of cytology and HPV testing is driven by the same factors as those fueling the North America market. In addition to these, the soaring demand for advanced imaging modalities and sensitive screening tests such as liquid-based cytology are anticipated to further accelerate the Europe market. Germany is the largest contributor to the Europe cytology and HPV testing market owing to the recent introduction and enhancement of various new technologies in the field of diagnostics. Government screening programs have also favorably benefited this regional market.

Emerging as one of the most attractive destinations for cytology and HPV testing as well as for the manufacturing of testing kits and systems, Asia Pacific is anticipated to witness immense growth during the forecast period. Thanks to the availability of low-cost and highly-skilled IT labor, leading companies such as Qiagen N.V. and Hologic Corporation have been setting up shop in APAC to capitalize on the opportunities presented by this region.

Although the RoW segment is also anticipated to witness a rise in the demand for cytology and HPV testing, especially in Africa, the narrow distribution network as well as the low awareness and adoption rate in several underdeveloped regions are likely to hamper market growth.

Modest Growth on the Cards

HPV testing services dominate the HPV testing market, accounting for a whopping 78.2% share in 2015 owing to an increasing number of women undergoing HPV tests for the detection and diagnosis of cervical cancer. Similarly, cytology testing services led the cytology testing market with a 78.7% share in 2015. This is due to the large number of PAP tests performed across the globe.

The soaring incidence of HPV infections and cervical cancer can be attributed to several risk factors, including the weakening of the immune system due to illness and a high number of sexual partners. Technological advancements in healthcare and growing awareness among the general population are also encouraging people to opt for high-accuracy diagnostic tests. Driven by these factors, the HPV testing market is expected to grow from US$7.9 bn in 2015 to US$10.5 bn by 2024 at a 2.9% CAGR therein.

Table of Contents

Chapter 1: Preface

  • 1.1. Report Description
  • 1.2. Research Methodology
  • 1.3. Market Segmentation

Chapter 2: Executive Summary

  • 2.1. Global Cytology and HPV Testing Market, Estimates and Forecast, By Revenue, 2014-2024(US$ Mn)
  • 2.2. Global HPV Testing Market, by Product and Services, 2015(US$ Mn)
  • 2.3. Global Cytology Testing Market, by Product and Services, 2015(US$ Mn)
  • 2.4. Global Market Share by Geography, 2015 and 2024(Value %)
  • 2.5. Cytology and HPV Testing Market Snapshot

Chapter 3: Cytology and HPV Testing Market - Market Analysis

  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Rising incidence of cervical cancer worldwide
    • 3.2.2. High incidence rate of HPV infections
    • 3.2.3. Increasing cervical cancer screening awareness programs
  • 3.3. Restraints
    • 3.3.1. Lack of appropriate primary healthcare infrastructure
    • 3.3.2. Low awareness of the global population hinders the growth of the market
  • 3.4. Opportunity
    • 3.4.1. Emerging economies to offer sustained growth opportunities
  • 3.5. Market Attractiveness Analysis - Global Cytology and HPV Testing Market
  • 3.6. Porter's Five Forces Analysis
  • 3.7. Competitive Landscape
    • 3.7.1. Market Positioning of Key Players
    • 3.7.2. Competitive Strategies adopted by Key Players
    • 3.7.3. Recommendations
  • 3.8. Epidemiology: HPV and Cervical Cancer
  • 3.9. Market Segmentation - By Product and Services
    • 3.9.1. Introduction - HPV Testing Market
    • 3.9.2. Global HPV Testing Systems Market Revenue, (US$ Mn), 2014-2024
    • 3.9.3. Global HPV Testing Assay Kits Market Revenue, (US$ Mn), 2014-2024
    • 3.9.4. Global HPV Testing Services Market Revenue, (US$ Mn), 2014-2024
  • 3.10. Market Segmentation - By Product and Services
    • 3.10.1. Introduction - Cytology Testing
    • 3.10.2. Global Cytology Testing Systems Market Revenue, (US$ Mn), 2014-2024
    • 3.10.3. Global Cytology Testing Assay Kits Market Revenue, (US$ Mn), 2014-2024
    • 3.10.4. Global Cytology Testing Services Market Revenue, (US$ Mn), 2014-2024

Chapter 4: Market Segmentation - By Region

  • 4.1. North America Cytology and HPV Testing Market Revenue, (US$ Mn), 2014-2024
    • 4.1.1. U.S.
    • 4.1.2. Canada
  • 4.2. Europe Cytology and HPV Testing Market Revenue, (US$ Mn), 2014-2024
    • 4.2.1. Germany
    • 4.2.2. France
    • 4.2.3. U.K.
  • 4.3. Asia Pacific Cytology and HPV Testing Market Revenue, (US$ Mn), 2014-2024
    • 4.3.1. Japan
    • 4.3.2. China
    • 4.3.3. Australia
  • 4.4. Rest of the World Cytology and HPV Testing Market Revenue, (US$ Mn), 2014-2024
    • 4.4.1. Brazil
    • 4.4.2. Mexico
    • 4.4.3. RoW

Chapter 5: Company Profiles

  • 5.1. Abbott Laboratories, Inc.
    • 5.1.1. Company Overview
    • 5.1.2. Financial Overview
    • 5.1.3. Product Portfolio
    • 5.1.4. Business Strategies
    • 5.1.5. Recent Development
  • 5.2. Arbor Vita Corporation
  • 5.3. Becton, Dickinson and Company
  • 5.4. Cepheid, Inc.
  • 5.5. F. Hoffmann-La Roche Ltd.
  • 5.6. Fujirebio Diagnostics, Inc.
  • 5.7. Hologic, Inc.
  • 5.8. OncoHealth Corporation
  • 5.9. QIAGEN N.V

List of Figures

  • FIG. 1: Global Cytology and HPV Testing Market Estimates and Forecast, (US$ Mn), 2014-2024
  • FIG. 2: Global HPV Testing Market Revenue, by Product and Services, (US$ Mn), 2015
  • FIG. 3: Global Cytology Testing Market Revenue, by Product and Services, (US$ Mn), 2015
  • FIG. 4: Global Cytology and HPV Testing Market, by Geography (%), 2015
  • FIG. 5: Global Cytology and HPV Testing Market, by Geography (%), 2024
  • FIG. 6: Market Attractiveness Analysis, by Geography (2015)
  • FIG. 7: Global Cytology Testing Market, by Key Players (%), 2015
  • FIG. 8: Global HPV Testing Market, by Key Players (%), 2015
  • FIG. 9: Global HPV Testing Systems Market Revenue, (US$ Mn), 2014-2024
  • FIG. 10: Global HPV Testing Assay Kits Market Revenue, (US$ Mn), 2014-2024
  • FIG. 11: Global HPV Testing Services Market Revenue, (US$ Mn), 2014-2024
  • FIG. 12: Global Cytology Testing Systems Market Revenue, (US$ Mn), 2014-2024
  • FIG. 13: Global Cytology Testing Assay Kits Market Revenue, (US$ Mn), 2014-2024
  • FIG. 14: Global Cytology Testing Services Market Revenue, (US$ Mn), 2014-2024
  • FIG. 15: U.S. Cytology and HPV Testing Market, by Revenue, (US$ Mn), 2014-2024
  • FIG. 16: Canada Cytology and HPV Testing Market, by Revenue, (US$ Mn), 2014-2024
  • FIG. 17: Germany Cytology and HPV Testing Market, (US$ Mn), 2014-2024
  • FIG. 18: France Cytology and HPV Testing Market, (US$ Mn), 2014-2024
  • FIG. 19: U.K. Cytology and HPV Testing Market, (US$ Mn), 2014-2024
  • FIG. 20: China Cytology and HPV Testing Market, (US$ Mn), 2014-2024
  • FIG. 21: Japan Cytology and HPV Testing Market, (US$ Mn), 2014-2024
  • FIG. 22: Australia Cytology and HPV Testing Market, (US$ Mn), 2014-2024
  • FIG. 23: Brazil Cytology and HPV Testing Market, (US$ Mn), 2014-2024
  • FIG. 24: Mexico Cytology and HPV Testing Market, (US$ Mn), 2014-2024
  • FIG. 25: Abbott Laboratories Financial Overview: (US$ Mn) 2013-2015
  • FIG. 26: Abbott Laboratories Operating Expenses: (US$ Mn) 2013-2015
  • FIG. 27: Becton, Dickinson and Company Financial Overview: (US$ Mn) 2013-2015
  • FIG. 28: Becton, Dickinson and Company Geographic Financial Overview: (US$ Mn), 2013-2015
  • FIG. 29: Cepheid, Inc. Financial Overview: (US$ Mn) 2013-2015
  • FIG. 30: Cepheid, Inc. Geographic Financial Overview: (US$ Mn), 2013-2015
  • FIG. 31: Cepheid, Inc. Operating Income: (US$ Mn), 2013-2015
  • FIG. 32: F. Hoffmann-La Roche Ltd Financial Overview: (US$ Mn), 2013-2015
  • FIG. 33: F. Hoffmann-La Roche Ltd Operating Profit: (US$ Mn) 2013-2015
  • FIG. 34: Hologic, Inc. Financial Overview: (US$ Mn), 2013-2015
  • FIG. 35: Hologic, Inc. Geographic Financial Overview: (US$ Mn), 2013-2015
  • FIG. 36: Hologic, Inc. Operating Income: (US$ Mn), 2013-2015
  • FIG. 37: QIAGEN N.V. Financial Overview: (US$ Mn), 2013-2015
  • FIG. 38: QIAGEN N.V. Operation Income Overview: (US$ Mn), 2013-2015

List of Tables

  • TABLE 1: Cytology and HPV Testing Market Snapshot
  • TABLE 2: Crude incidence of HPV-related cervical cancer per 100,000 women population
  • TABLE 3: Global HPV Testing Market Estimates and Forecast, by Product and Services, (US$ Mn), 2014-2024
  • TABLE 4: Global Cytology Testing Market Estimates and Forecast, by Product and Services, (US$ Mn), 2014-2024
  • TABLE 5: North America HPV Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014-2024
  • TABLE 6: North America Cytology Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014-2024
  • TABLE 7: North America Cytology and HPV Testing Market Revenue, by Country, (US$ Mn), 2014-2024
  • TABLE 8: Europe HPV Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014-2024
  • TABLE 9: Europe Cytology Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014-2024
  • TABLE 10: Europe Cytology and HPV Testing Market Revenue, by Country, (US$ Mn), 2014-2024
  • TABLE 11: Asia Pacific HPV Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014-2024
  • TABLE 12: Asia Pacific Cytology Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014-2024
  • TABLE 13: Asia Pacific Cytology and HPV Testing Market Revenue, by Country, (US$ Mn), 2014-2024
  • TABLE 14: Rest of the World HPV Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014-2024
  • TABLE 15: Rest of the World Cytology Testing Market Estimates and Forecast, by Products and Services, (US$ Mn), 2014-2024
  • TABLE 16: Rest of the World Cytology and HPV Testing Market Revenue, by Country, (US$ Mn), 2014-2024
Back to Top